Noura M, Morita K, Kiyose H, Matsuo H, Nishinaka-Arai Y, Kurokawa M, Kamikubo Y, Adachi S |
Noura M, Morita K, Kiyose H, Matsuo H, Nishinaka-Arai Y, Kurokawa M, Kamikubo Y, Adachi S |
Noura M, Morita K, Kiyose H, Matsuo H, Nishinaka-Arai Y, Kurokawa M, Kamikubo Y, Adachi S |
Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells. |
Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells. |
Pivotal role of DPYSL2A in KLF4-mediated monocytic differentiation of acute myeloid leukemia cells. |
Sci Rep. 2020 Nov 20;10(1):20245. |
Sci Rep. 2020 Nov 20;10(1):20245. |
Sci Rep. 2020 Nov 20;10(1):20245. |
2020/11 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Matsuo H, Wakita T, Hiramatsu H, Ohmori K, Kodama K, Nakatani K, Kamikubo Y, Iwamoto S, Kondo T, Takaori-Kondo A, Takita J, Tomizawa D, Taga T, Adachi S |
Matsuo H, Wakita T, Hiramatsu H, Ohmori K, Kodama K, Nakatani K, Kamikubo Y, Iwamoto S, Kondo T, Takaori-Kondo A, Takita J, Tomizawa D, Taga T, Adachi S |
Matsuo H, Wakita T, Hiramatsu H, Ohmori K, Kodama K, Nakatani K, Kamikubo Y, Iwamoto S, Kondo T, Takaori-Kondo A, Takita J, Tomizawa D, Taga T, Adachi S |
Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression. |
Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression. |
Blast cells in acute megakaryoblastic leukaemia with Down syndrome are characterized by low CLEC12A expression. |
Br J Haematol. 2020 Oct 23. Online ahead of print. |
Br J Haematol. 2020 Oct 23. Online ahead of print. |
|
2020/10 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Nakatani K*, Matsuo H*, Harata Y, Higashitani M, Koyama A, Noura M, Nishinaka-Arai Y, Kamikubo Y, Adachi S, *equal contribution. |
Nakatani K*, Matsuo H*, Harata Y, Higashitani M, Koyama A, Noura M, Nishinaka-Arai Y, Kamikubo Y, Adachi S, *equal contribution. |
Nakatani K*, Matsuo H*, Harata Y, Higashitani M, Koyama A, Noura M, Nishinaka-Arai Y, Kamikubo Y, Adachi S, *equal contribution. |
Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells. |
Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells. |
Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells. |
Int J Hematol. 2020 Oct 17. Online ahead of print. |
Int J Hematol. 2020 Oct 17. Online ahead of print. |
Int J Hematol. 2020 Oct 17. Online ahead of print. |
2020/10 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Matsuo H, Yoshida K, Nakatani K, Harata Y, Higashitani M, Ito Y, Kamikubo Y, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Miyano S, Meggendorfer M, Haferlach C, Ogawa S, Adachi S |
Matsuo H, Yoshida K, Nakatani K, Harata Y, Higashitani M, Ito Y, Kamikubo Y, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Miyano S, Meggendorfer M, Haferlach C, Ogawa S, Adachi S |
Matsuo H, Yoshida K, Nakatani K, Harata Y, Higashitani M, Ito Y, Kamikubo Y, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Miyano S, Meggendorfer M, Haferlach C, Ogawa S, Adachi S |
Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.  |
Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.  |
Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.  |
Blood Adv. 2020 Oct 13;4(19):4623-4631. |
Blood Adv. 2020 Oct 13;4(19):4623-4631. |
Blood Adv. 2020 Oct 13;4(19):4623-4631. |
2020/10 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Noura M, Matsuo H, Koyama A, Adachi S, Masutani H |
Noura M, Matsuo H, Koyama A, Adachi S, Masutani H |
Noura M, Matsuo H, Koyama A, Adachi S, Masutani H |
TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells.  |
TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells.  |
TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells.  |
FEBS Open Bio. 2020 Aug;10(8):1532-1541. |
FEBS Open Bio. 2020 Aug;10(8):1532-1541. |
FEBS Open Bio. 2020 Aug;10(8):1532-1541. |
2020/08 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Saito Y, Sawa D, Kinoshita M, Yamada A, Kamimura S, Suekane A, Ogoh H, Matsuo H, Adachi S, Taga T, Tomizawa D, Osato M, Soga T, Morishita K, Moritake H. |
Saito Y, Sawa D, Kinoshita M, Yamada A, Kamimura S, Suekane A, Ogoh H, Matsuo H, Adachi S, Taga T, Tomizawa D, Osato M, Soga T, Morishita K, Moritake H |
Saito Y, Sawa D, Kinoshita M, Yamada A, Kamimura S, Suekane A, Ogoh H, Matsuo H, Adachi S, Taga T, Tomizawa D, Osato M, Soga T, Morishita K, Moritake H. |
EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase. |
EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase. |
EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase. |
Haematologica. 2020 Aug;105(8):2118-2129. |
Haematologica. 2020 Aug;105(8):2118-2129. |
Haematologica. 2020 Aug;105(8):2118-2129. |
2020/08 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Matsuo H, Imamura A, Shimizu M, Inagaki M, Tsuji Y, Nakabo S, Hashimoto M, Ito H, Tanaka S, Mimori T, Fujii Y |
Matsuo H, Imamura A, Shimizu M, Inagaki M, Tsuji Y, Nakabo S, Hashimoto M, Ito H, Tanaka S, Mimori T, Fujii Y |
Matsuo H, Imamura A, Shimizu M, Inagaki M, Tsuji Y, Nakabo S, Hashimoto M, Ito H, Tanaka S, Mimori T, Fujii Y |
Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis. |
Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis. |
Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis. |
J Med Ultrason (2001). 2020 Jan;47(1):131-138. |
J Med Ultrason (2001). 2020 Jan;47(1):131-138. |
J Med Ultrason (2001). 2020 Jan;47(1):131-138. |
2020/01 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Shiba N, Yoshida K, Hara Y, Yamato G, Shiraishi Y, Matsuo H, Okuno Y, Chiba K, Tanaka H, Kaburagi T, Takeuchi M, Ohki K, Sanada M, Okubo J, Tomizawa D, Taki T, Shimada A, Sotomatsu M, Horibe K, Taga T, Adachi S, Tawa A, Miyano S, Ogawa S, Hayashi Y |
Shiba N, Yoshida K, Hara Y, Yamato G, Shiraishi Y, Matsuo H, Okuno Y, Chiba K, Tanaka H, Kaburagi T, Takeuchi M, Ohki K, Sanada M, Okubo J, Tomizawa D, Taki T, Shimada A, Sotomatsu M, Horibe K, Taga T, Adachi S, Tawa A, Miyano S, Ogawa S, Hayashi Y |
Shiba N, Yoshida K, Hara Y, Yamato G, Shiraishi Y, Matsuo H, Okuno Y, Chiba K, Tanaka H, Kaburagi T, Takeuchi M, Ohki K, Sanada M, Okubo J, Tomizawa D, Taki T, Shimada A, Sotomatsu M, Horibe K, Taga T, Adachi S, Tawa A, Miyano S, Ogawa S, Hayashi Y |
Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. |
Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. |
Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. |
Blood Adv. 2019 Oct 22;3(20):3157-3169. |
Blood Adv. 2019 Oct 22;3(20):3157-3169. |
Blood Adv. 2019 Oct 22;3(20):3157-3169. |
2019/10 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Matsuo H, Yoshida K, Fukumura K, Nakatani K, Noguchi Y, Takasaki S, Noura M, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Shiba N, Yamato G, Handa H, Ono Y, Hiramoto N, Ishikawa T, Usuki K, Ishiyama K, Miyawaki S, Itonaga H, Miyazaki Y, Kawamura M, Yamaguchi H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Hayashi Y, Mano H, Miyano S, Kamikubo Y, Ogawa S, Adachi S |
Matsuo H, Yoshida K, Fukumura K, Nakatani K, Noguchi Y, Takasaki S, Noura M, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Shiba N, Yamato G, Handa H, Ono Y, Hiramoto N, Ishikawa T, Usuki K, Ishiyama K, Miyawaki S, Itonaga H, Miyazaki Y, Kawamura M, Yamaguchi H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Hayashi Y, Mano H, Miyano S, Kamikubo Y, Ogawa S, Adachi S |
Matsuo H, Yoshida K, Fukumura K, Nakatani K, Noguchi Y, Takasaki S, Noura M, Shiozawa Y, Shiraishi Y, Chiba K, Tanaka H, Okada A, Nannya Y, Takeda J, Ueno H, Shiba N, Yamato G, Handa H, Ono Y, Hiramoto N, Ishikawa T, Usuki K, Ishiyama K, Miyawaki S, Itonaga H, Miyazaki Y, Kawamura M, Yamaguchi H, Kiyokawa N, Tomizawa D, Taga T, Tawa A, Hayashi Y, Mano H, Miyano S, Kamikubo Y, Ogawa S, Adachi S |
Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.  |
Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.  |
Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.  |
Blood Adv. 2018 Nov 13;2(21):2879-2889. |
Blood Adv. 2018 Nov 13;2(21):2879-2889. |
Blood Adv. 2018 Nov 13;2(21):2879-2889. |
2018/11 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Matsuo H, Handa T, Tsuchiya M, Kubo T, Yoshizawa A, Nakayama Y, Shiga S, Hitomi T, Adachi S, Date H, Hirai T, Ichiyama S |
Matsuo H, Handa T, Tsuchiya M, Kubo T, Yoshizawa A, Nakayama Y, Shiga S, Hitomi T, Adachi S, Date H, Hirai T, Ichiyama S |
Matsuo H, Handa T, Tsuchiya M, Kubo T, Yoshizawa A, Nakayama Y, Shiga S, Hitomi T, Adachi S, Date H, Hirai T, Ichiyama S |
Progressive Restrictive Ventilatory Impairment in Idiopathic Diffuse Pulmonary Ossification. |
Progressive Restrictive Ventilatory Impairment in Idiopathic Diffuse Pulmonary Ossification. |
Progressive Restrictive Ventilatory Impairment in Idiopathic Diffuse Pulmonary Ossification. |
Intern Med. 2018 Jun 1;57(11):1631-1636. |
Intern Med. 2018 Jun 1;57(11):1631-1636. |
Intern Med. 2018 Jun 1;57(11):1631-1636. |
2018/06 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Matsuo H, Iijima-Yamashita Y, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K |
Matsuo H, Iijima-Yamashita Y, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K |
|
Monitoring of fusion gene transcripts to predict relapses in pediatric acute myeloid leukemia. |
Monitoring of fusion gene transcripts to predict relapses in pediatric acute myeloid leukemia. |
Monitoring of fusion gene transcripts to predict relapses in pediatric acute myeloid leukemia. |
Pediatr Int. 2018 Jan;60(1):41-46. |
Pediatr Int. 2018 Jan;60(1):41-46. |
Pediatr Int. 2018 Jan;60(1):41-46. |
2018/01 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Iijima-Yamashita Y*, Matsuo H*, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Takahashi H, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K, *equal contribution. |
Iijima-Yamashita Y*, Matsuo H*, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Takahashi H, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K, *equal contribution. |
Iijima-Yamashita Y*, Matsuo H*, Yamada M, Deguchi T, Kiyokawa N, Shimada A, Tawa A, Takahashi H, Tomizawa D, Taga T, Kinoshita A, Adachi S, Horibe K, *equal contribution. |
Multiplex fusion gene testing in pediatric acute myeloid leukemia. |
Multiplex fusion gene testing in pediatric acute myeloid leukemia. |
Multiplex fusion gene testing in pediatric acute myeloid leukemia. |
Pediatr Int. 2018 Jan;60(1):47-51. |
Pediatr Int. 2018 Jan;60(1):47-51. |
Pediatr Int. 2018 Jan;60(1):47-51. |
2018/01 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Morita K, Noura M, Tokushige C, Maeda S, Kiyose H, Kashiwazaki G, Taniguchi J, Bando T, Yoshida K, Ozaki T, Matsuo H, Ogawa S, Liu PP, Nakahata T, Sugiyama H, Adachi S, Kamikubo Y |
Morita K, Noura M, Tokushige C, Maeda S, Kiyose H, Kashiwazaki G, Taniguchi J, Bando T, Yoshida K, Ozaki T, Matsuo H, Ogawa S, Liu PP, Nakahata T, Sugiyama H, Adachi S, Kamikubo Y |
Morita K, Noura M, Tokushige C, Maeda S, Kiyose H, Kashiwazaki G, Taniguchi J, Bando T, Yoshida K, Ozaki T, Matsuo H, Ogawa S, Liu PP, Nakahata T, Sugiyama H, Adachi S, Kamikubo Y |
Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.  |
Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.  |
Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.  |
Sci Rep. 2017 Nov 30;7(1):16604. |
Sci Rep. 2017 Nov 30;7(1):16604. |
Sci Rep. 2017 Nov 30;7(1):16604. |
2017/11 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Nakayama H, Tomizawa D, Tanaka S, Iwamoto S, Shimada A, Saito AM, Yamashita Y, Moritake H, Terui K, Taga T, Matsuo H, Kosaka Y, Koh K, Hosoi H, Kurosawa H, Isoyama K, Horibe K, Mizutani S, Adachi S |
Nakayama H, Tomizawa D, Tanaka S, Iwamoto S, Shimada A, Saito AM, Yamashita Y, Moritake H, Terui K, Taga T, Matsuo H, Kosaka Y, Koh K, Hosoi H, Kurosawa H, Isoyama K, Horibe K, Mizutani S, Adachi S |
|
Fludarabine, cytarabine, G-CSF and idarubicin for children with relapsed AML. |
Fludarabine, cytarabine, G-CSF and idarubicin for children with relapsed AML. |
Fludarabine, cytarabine, G-CSF and idarubicin for children with relapsed AML. |
Pediatr Int. 2017 Oct;59(10):1046-1052. |
Pediatr Int. 2017 Oct;59(10):1046-1052. |
Pediatr Int. 2017 Oct;59(10):1046-1052. |
2017/10 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Matsuo H, Shiga S, Imai T, Kamikubo Y, Toki T, Terui K, Ito E, Adachi S |
Matsuo H, Shiga S, Imai T, Kamikubo Y, Toki T, Terui K, Ito E, Adachi S |
Matsuo H, Shiga S, Imai T, Kamikubo Y, Toki T, Terui K, Ito E, Adachi S |
Purification of leukemic blast cells from blood smears using laser microdissection. |
Purification of leukemic blast cells from blood smears using laser microdissection. |
Purification of leukemic blast cells from blood smears using laser microdissection. |
Int J Hematol. 2017 Jul;106(1):55-59. |
Int J Hematol. 2017 Jul;106(1):55-59. |
Int J Hematol. 2017 Jul;106(1):55-59. |
2017/07 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Morita K, Suzuki K, Maeda S, Matsuo A, Mitsuda Y, Tokushige C, Kashiwazaki G, Taniguchi J, Maeda R, Noura M, Hirata M, Kataoka T, Yano A, Yamada Y, Kiyose H, Tokumasu M, Matsuo H, Tanaka S, Okuno Y, Muto M, Naka K, Ito K, Kitamura T, Kaneda Y, Liu PP, Bando T, Adachi S, Sugiyama H, Kamikubo Y |
Morita K, Suzuki K, Maeda S, Matsuo A, Mitsuda Y, Tokushige C, Kashiwazaki G, Taniguchi J, Maeda R, Noura M, Hirata M, Kataoka T, Yano A, Yamada Y, Kiyose H, Tokumasu M, Matsuo H, Tanaka S, Okuno Y, Muto M, Naka K, Ito K, Kitamura T, Kaneda Y, Liu PP, Bando T, Adachi S, Sugiyama H, Kamikubo Y |
Morita K, Suzuki K, Maeda S, Matsuo A, Mitsuda Y, Tokushige C, Kashiwazaki G, Taniguchi J, Maeda R, Noura M, Hirata M, Kataoka T, Yano A, Yamada Y, Kiyose H, Tokumasu M, Matsuo H, Tanaka S, Okuno Y, Muto M, Naka K, Ito K, Kitamura T, Kaneda Y, Liu PP, Bando T, Adachi S, Sugiyama H, Kamikubo Y |
Genetic regulation of the RUNX transcription factor family has antitumor effects. |
Genetic regulation of the RUNX transcription factor family has antitumor effects. |
Genetic regulation of the RUNX transcription factor family has antitumor effects. |
J Clin Invest. 2017 Jun 30;127(7):2815-2828. |
J Clin Invest. 2017 Jun 30;127(7):2815-2828. |
J Clin Invest. 2017 Jun 30;127(7):2815-2828. |
2017/06 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Matsuo H, Nakamura N, Tomizawa D, Saito AM, Kiyokawa N, Horibe K, Nishinaka-Arai Y, Tokumasu M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S |
Matsuo H, Nakamura N, Tomizawa D, Saito AM, Kiyokawa N, Horibe K, Nishinaka-Arai Y, Tokumasu M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S |
Matsuo H, Nakamura N, Tomizawa D, Saito AM, Kiyokawa N, Horibe K, Nishinaka-Arai Y, Tokumasu M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S |
CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group. |
CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group. |
CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group. |
Pediatr Blood Cancer. 2016 Aug;63(8):1394-9. |
Pediatr Blood Cancer. 2016 Aug;63(8):1394-9. |
Pediatr Blood Cancer. 2016 Aug;63(8):1394-9. |
2016/08 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Matsuo H, Itoh H, Kitamura N, Kamikubo Y, Higuchi T, Shiga S, Ichiyama S, Kondo T, Takaori-Kondo A, Adachi S |
Matsuo H, Itoh H, Kitamura N, Kamikubo Y, Higuchi T, Shiga S, Ichiyama S, Kondo T, Takaori-Kondo A, Adachi S |
Matsuo H, Itoh H, Kitamura N, Kamikubo Y, Higuchi T, Shiga S, Ichiyama S, Kondo T, Takaori-Kondo A, Adachi S |
Intravenous immunoglobulin enhances the killing activity and autophagy of neutrophils isolated from immunocompromised patients against multidrug-resistant bacteria. |
Intravenous immunoglobulin enhances the killing activity and autophagy of neutrophils isolated from immunocompromised patients against multidrug-resistant bacteria. |
Intravenous immunoglobulin enhances the killing activity and autophagy of neutrophils isolated from immunocompromised patients against multidrug-resistant bacteria. |
Biochem Biophys Res Commun. 2015 Aug 14;464(1):94-9. |
Biochem Biophys Res Commun. 2015 Aug 14;464(1):94-9. |
Biochem Biophys Res Commun. 2015 Aug 14;464(1):94-9. |
2015/08 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Itoh H*, Matsuo H*, Kitamura N, Yamamoto S, Higuchi T, Takematsu H, Kamikubo Y, Kondo T, Yamashita K, Sasada M, Takaori-Kondo A, Adachi S, *equal contribution. |
Itoh H*, Matsuo H*, Kitamura N, Yamamoto S, Higuchi T, Takematsu H, Kamikubo Y, Kondo T, Yamashita K, Sasada M, Takaori-Kondo A, Adachi S, *equal contribution. |
Itoh H*, Matsuo H*, Kitamura N, Yamamoto S, Higuchi T, Takematsu H, Kamikubo Y, Kondo T, Yamashita K, Sasada M, Takaori-Kondo A, Adachi S, *equal contribution. |
Enhancement of neutrophil autophagy by an IVIG preparation against multidrug-resistant bacteria as well as drug-sensitive strains. |
Enhancement of neutrophil autophagy by an IVIG preparation against multidrug-resistant bacteria as well as drug-sensitive strains. |
Enhancement of neutrophil autophagy by an IVIG preparation against multidrug-resistant bacteria as well as drug-sensitive strains. |
J Leukoc Biol. 2015 Jul;98(1):107-17. |
J Leukoc Biol. 2015 Jul;98(1):107-17. |
J Leukoc Biol. 2015 Jul;98(1):107-17. |
2015/07 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Matsuo H, Goyama S, Kamikubo Y, Adachi S |
Matsuo H, Goyama S, Kamikubo Y, Adachi S |
Matsuo H, Goyama S, Kamikubo Y, Adachi S |
The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia. |
The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia. |
The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia. |
Haematologica. 2015 Mar;100(3):e116-7. |
Haematologica. 2015 Mar;100(3):e116-7. |
Haematologica. 2015 Mar;100(3):e116-7. |
2015/03 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Shiba N, Ohki K, Hayashi Y, Yamashita Y, Shimada A, Tanaka S, Adachi S |
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Shiba N, Ohki K, Hayashi Y, Yamashita Y, Shimada A, Tanaka S, Adachi S |
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Shiba N, Ohki K, Hayashi Y, Yamashita Y, Shimada A, Tanaka S, Adachi S |
EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia. |
EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia. |
EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia. |
Haematologica. 2014 Nov;99(11):e225-7. |
Haematologica. 2014 Nov;99(11):e225-7. |
Haematologica. 2014 Nov;99(11):e225-7. |
2014/11 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Kinoshita A, Miyachi H, Matsushita H, Yabe M, Taki T, Watanabe T, Saito AM, Tomizawa D, Taga T, Takahashi H, Matsuo H, Kodama K, Ohki K, Hayashi Y, Tawa A, Horibe K, Adachi S |
Kinoshita A, Miyachi H, Matsushita H, Yabe M, Taki T, Watanabe T, Saito AM, Tomizawa D, Taga T, Takahashi H, Matsuo H, Kodama K, Ohki K, Hayashi Y, Tawa A, Horibe K, Adachi S |
Kinoshita A, Miyachi H, Matsushita H, Yabe M, Taki T, Watanabe T, Saito AM, Tomizawa D, Taga T, Takahashi H, Matsuo H, Kodama K, Ohki K, Hayashi Y, Tawa A, Horibe K, Adachi S |
Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group. |
Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group. |
Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group. |
Br J Haematol. 2014 Oct;167(1):80-6. |
Br J Haematol. 2014 Oct;167(1):80-6. |
Br J Haematol. 2014 Oct;167(1):80-6. |
2014/10 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S |
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S |
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S |
Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group. |
Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group. |
Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group. |
Blood Cancer J. 2014 Jul 11;4(7):e226. |
Blood Cancer J. 2014 Jul 11;4(7):e226. |
Blood Cancer J. 2014 Jul 11;4(7):e226. |
2014/07 |
Refereed |
English |
Research paper(scientific journal) |
Disclose to all |